| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Adial Pharmaceuticals, Inc. (ADIL) has 7 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. ADIL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 138.0K | $190.4K | - | |
| COO | 94.0K | $129.7K | - | |
| Dir | 28.0K | $38.6K | - | |
| Dir | 28.0K | $38.6K | - | |
| Dir | 28.0K | $38.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 29, 2019 | Johnson Bankole A. | Chief Medical Officer | Buy | 73,100 | $3.29 | $240,609.02 | +5.7% | |
| Jul 31, 2018 | Gilliland Robertson H. | Director | Buy | 14,000 | $0.00 | - | +14.7% | |
| Jul 31, 2018 | Newman James W. Jr. | Director | Buy | 20,000 | $0.00 | - | +14.2% | |
| Jul 31, 2018 | Stilley William B. III | Chief Executive Officer | Buy | 80,000 | $0.00 | - | +18.9% | |
| Jul 31, 2018 | Schuyler Kevin | Director | Buy | 90,000 | $0.00 | - | +35.5% | |
| Jul 31, 2018 | Goodman Tony | Director | Buy | 7,000 | $0.00 | - | +398.9% | |
| Jul 31, 2018 | Johnson Bankole A. | Director, 10% Owner | Buy | 1,400 | $0.00 | - | New |